The dysregulation of IL‐18 and IL‐18BP is significantly associated with immune‐mediated diseases, especially those where IFNγ plays a pathological role, such as macrophage activation syndrome (MAS) [69]. Here, IL18BP is linked to macrophage activation syndrome.